Patents by Inventor Michael Edward Donald Crothers

Michael Edward Donald Crothers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Compositions
    Publication number: 20180289654
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Application
    Filed: November 17, 2017
    Publication date: October 11, 2018
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic compositions
    Patent number: 9861603
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: January 9, 2018
    Assignee: LEO Laboratories Limited
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic compositions
    Patent number: 9833429
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: December 5, 2017
    Assignee: LEO Laboratories Limited
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic compositions
    Patent number: 9820959
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: November 21, 2017
    Assignee: LEO Laboratories Limited
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic compositions
    Patent number: 9603822
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: March 28, 2017
    Assignee: LEO Laboratories Limited
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic Compositions
    Publication number: 20160263069
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Application
    Filed: May 24, 2016
    Publication date: September 15, 2016
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic Compositions
    Publication number: 20160263070
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Application
    Filed: May 24, 2016
    Publication date: September 15, 2016
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic Compositions
    Publication number: 20160263068
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Application
    Filed: May 24, 2016
    Publication date: September 15, 2016
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Therapeutic Compositions
    Publication number: 20160263067
    Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilised by dissolving it in an aprotic solvent in the presence of an acidic buffer.
    Type: Application
    Filed: May 24, 2016
    Publication date: September 15, 2016
    Inventors: Marc Barry Brown, Michael Edward Donald Crothers, Tahir Nazir
  • Antimicrobial Composition
    Publication number: 20080140036
    Abstract: The present invention relates to a composition for use as an antimicrobial medicament comprising a biocidally active compound. The invention also relates to a medicament comprising at least one biocidally active compound and a fungal cell or fungal cell fragment wherein molecules of the at least one biocidally active compound are encapsulated or partially encapsulated by the fungal cell or fungal cell fragment.
    Type: Application
    Filed: January 18, 2005
    Publication date: June 12, 2008
    Inventors: Rachael Buck, Michael Edward Donald Crothers, Gordon Nelson